TSE:LEAFMedReleaf Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding MedReleaf Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day RangeC$24.47MA: C$24.47▼C$24.4752-Week Range N/AVolume758,368 shsAverage Volume729,112 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsInsider TradesHeadlinesOptions ChainSocial Media MedReleaf Corp. produces and sells cannabis-based pharmaceutical products in Canada. It offers dried cannabis, cannabis oils, and cannabis oil capsules; and various accessories, including grinders, vaporizers, and lockable containers. The company was incorporated in 2013 and is headquartered in Markham, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for MedReleaf. Previous Next 2.5 Community Rank Outperform VotesMedReleaf has received 168 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMedReleaf has received 170 “underperform” votes. (Add your “underperform” vote.)Community SentimentMedReleaf has received 50.30% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about MedReleaf and other stocks. Vote “Outperform” if you believe LEAF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LEAF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMedReleaf does not currently pay a dividend.Dividend GrowthMedReleaf does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, MedReleaf insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange TSE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryCannabis SectorMedical Current SymbolTSE:LEAF Previous Symbol CUSIPN/A CIKN/A Webmedreleaf.com PhoneN/ADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable TSX:LEAF Rates by TradingView Receive LEAF News and Ratings via Email Sign-up to receive the latest news and ratings for LEAF and its competitors with MarketBeat's FREE daily newsletter. MedReleaf (TSE:LEAF) Frequently Asked Questions Has MedReleaf been receiving favorable news coverage? Press coverage about LEAF stock has been trending extremely negative on Saturday, InfoTrie Sentiment reports. The research group rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. MedReleaf earned a coverage optimism score of -5.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutMedReleaf. Who are some of MedReleaf's key competitors? Some companies that are related to MedReleaf include Canopy Growth (WEED), Canopy Growth (CGC), Innovative Industrial Properties (IIPR), OrganiGram (OGI), GrowGeneration (GRWG), Emblem (EMC), ICC Labs (ICC), Bioventix (BVXP), KushCo (KSHB), 22nd Century Group (XXII), Terra Tech (TRTC), General Cannabis (CANN), mCig (MCIG), Nemus Bioscience (NMUS) and Grow Capital (GRWC). View all competitors. What other stocks do shareholders of MedReleaf own? Based on aggregate information from My MarketBeat watchlists, some companies that other MedReleaf investors own include Canopy Growth (WEED), Aurora Cannabis (ACB), Aurora Cannabis (ACB), Canopy Growth (CGC), GW Pharmaceuticals PLC- (GWPH), Aurora Cannabis (ACBFF), Cronos Group (CRON), CannTrust (CTST), OrganiGram (OGI) and Energous (WATT). Who are MedReleaf's key executives? MedReleaf's management team includes the following people: Mr. Neil J. Closner, CEO, Co-Founder & DirectorMr. Igor Gimelshtein, CFO & Corp. Sec.Mr. Donald Courtney, Chief Operating OfficerMs. Christie Hall, VP of Fin. & AccountingDr. Jeremy N. Friedberg, Chief Science Officer What is MedReleaf's stock symbol? MedReleaf trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LEAF." How do I buy shares of MedReleaf? Shares of LEAF and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is MedReleaf's official website? The official website for MedReleaf is medreleaf.com. This page was last updated on 6/6/2020 by MarketBeat.com Staff
